Rep. Carol D. Miller

Maddy summaryThis bill designates the location for the National Medal of Honor Monument, which was previously authorized by Public Law 117-80. It specifies that the monument must be placed within the National Mall's "Reserve" area near the Lincoln Memorial, overriding a prior location requirement. The bill does not create new policies or funding but clarifies the physical site for the existing authorized monument honoring Medal of Honor recipients. It directly affects the National Medal of Honor Museum Foundation, which will manage the monument's construction and placement.

Maddy summaryThis bill amends the Natural Gas Act to give the Federal Energy Regulatory Commission (FERC) exclusive authority to approve U.S. LNG export terminal projects, requiring FERC to deem such exports consistent with the public interest. It directly affects natural gas companies seeking to build or expand export facilities and streamlines FERC's review process by removing prior requirements for interagency coordination. The bill clarifies that FERC's decisions won't override existing sanctions laws, including restrictions on trade with countries designated as state sponsors of terrorism under current law. This change aims to accelerate domestic LNG export projects while maintaining legal safeguards for national security and foreign policy.

Maddy summaryThis bill removes barriers for people with past drug-related convictions to access federal assistance programs. It amends welfare law to allow states to provide Temporary Assistance for Needy Families (TANF) benefits to individuals with such convictions and prohibits states from denying Supplemental Nutrition Assistance Program (SNAP) benefits based on drug convictions. The bill also adds "incarcerated individuals scheduled for release within 30 days" to SNAP household eligibility criteria. These changes directly affect individuals with past drug convictions seeking welfare or food assistance, removing state-level restrictions that previously barred them.

Maddy summaryHR 6446 modifies how U.S. customs officials investigate suspected evasion of antidumping and countervailing duty orders on imported goods. It allows the Commissioner to start an investigation independently if they have evidence of evasion, not just when a complaint is filed. Additionally, importers found to have evaded duties must pay all owed customs fees before they can challenge the decision in court. These changes streamline enforcement and clarify the process for addressing duty evasion.

Maddy summaryThis bill creates two federal grant programs to support medical residency training in rural areas. The first program provides grants to eligible organizations (like rural hospitals, health centers, and medical schools) to establish or expand residency programs where doctors train in rural settings for over half their residency time, focusing on primary care, high-need specialties, or maternal health. The second program funds technical assistance grants to help these organizations apply for and run the training programs. The bill authorizes $12.7 million annually from 2026 to 2030, with grants for the training programs lasting up to 3 years and technical assistance grants up to 4 years.

Maddy summaryHR 6407, the RCORP Authorization Act, authorizes $165 million annually (2026-2030) to fund the Rural Communities Opioid Response Program. This program provides grants to states, tribes, rural health offices, and other eligible entities to expand prevention, treatment, and recovery services for opioid and substance use disorders in rural areas. Funds can support planning, evidence-based service models, and coordination with local communities but cannot be used for real property acquisition. The bill directly affects rural communities facing opioid crises and the organizations delivering care through these grants.

Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research.  Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research.  The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)

Maddy summaryThis bill allows workers aged 50 or older to directly roll over employer retirement contributions (from 401(k) plans) into an individual retirement annuity without triggering immediate taxes or penalties. It requires retirement plan administrators to provide clear, plain-language written explanations about rollover rules, including a 30-day review period, tax implications (like the 10% early withdrawal penalty), and what types of distributions cannot be rolled over (such as required minimum distributions). The rules apply to taxable years starting after December 31, 2025, and aim to simplify the process for older workers changing jobs or managing retirement funds. It directly affects workers aged 50+ and retirement plan administrators who must comply with the new disclosure standards.

Maddy summaryThis bill would expand Medicare Part B coverage to include medical nutrition therapy for beneficiaries with a wider range of chronic conditions beyond current limits (diabetes and kidney disease). It specifically adds conditions like obesity, hypertension, eating disorders, cancer, gastrointestinal diseases, and HIV to the list of covered illnesses, allowing coverage for prevention, management, or treatment. The bill also allows more healthcare providers - including dietitians, nurse practitioners, and clinical psychologists - to deliver these services. This change would directly affect millions of Medicare beneficiaries managing these conditions who previously lacked coverage for medically necessary nutrition therapy.

Maddy summaryThe Kidney Care Access Protection Act (HR 6214) improves access to innovative kidney treatments for Medicare beneficiaries with end-stage renal disease. It extends transitional payment adjustments for new renal dialysis drugs and devices for at least three years, then establishes permanent payment adjustments based on actual utilization and costs. The bill also expands Medicare's annual wellness benefit to include kidney disease screening and increases access to kidney disease education services through renal dialysis facilities. These changes apply to Medicare beneficiaries, renal dialysis facilities, and healthcare providers, with key provisions effective January 1, 2026.